Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

NCT01049984 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Rasagiline
DRUG: Placebo

Sponsor

Teva Neuroscience, Inc.

Collaborators

[object Object]